摘要:052详见(《南京医药股份有限公司2007年第三季度报告》)。......
3,661,035.28
| 5,220,473.63
| 减:营业外支出
| 72,678.43
| 1,686,651.82
| 2,006,876.42
| 4,769,448.66
|
其中:非流动资产处置
净损失
|
|
|
|
|
四、利润总额(亏损总额以“-”
号填列)
| 26,489,140.68
| 9,794,237.70
| 73,052,994.11
| 28,361,407.13
|
减:所得税费用
| 5,822,829.87
| 3,429,493.97
| 23,416,876.05
| 8,476,197.52
|
五、净利润(净亏损以
“-”号填列)
| 20,666,310.81
| 6,364,743.73
| 49,636,118.06
| 19,885,209.61
|
归属于母公司所有者的净利润
| 14,844,931.37
| 4,545,815.43
| 35,076,811.35
| 12,919,208.54
|
少数股东损益
| 5,821,379.44
| 1,818,928.29
| 14,559,306.71
| 6,966,001.06
|
六、每股收益:
|
关键字:
|